OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 14, 2021
The collaboration between Intellia and SparingVision will work to develop genomic medicines for ocular diseases.
This acquisition grants Bionano access to BioDiscovery’s clinical software solution for variant analysis.
Pharmalex has launched the Biopharma Excellence brand, a new service line that combines the expertise of PharmaLex, ERA Consulting, and Biopharma Excellence.
SGS is investing in a new E&L lab in Navi Mumbai, India, that will provide testing services.
AION Labs will be a first-of-its-kind AI/pharma and computational biology innovation lab aimed at spearheading the adoption of AI technologies and computational science.
Element’s acquisition of Nanosyn is the latest in a series of moves made to strengthen the company’s North American presence.
October 13, 2021
Pacira’s acquisition grants them access to Flexion’s pain management portfolio.
October 12, 2021
Supernus will acquire Adamas’ Parkinson's disease treatment portfolio through a $400 million acquisition.
October 08, 2021
Pfizer may pay up to $630 million for access to Voyager’s novel AAV capsids in transgene research.
October 06, 2021
The collaboration between Sunovion, Sumitomo Dainippon, and Otsuka will focus on four compounds designed to treat neuropsychiatric health conditions.